Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002317625 | SCV000851238 | uncertain significance | Inborn genetic diseases | 2016-09-13 | criteria provided, single submitter | clinical testing | The p.Y14C variant (also known as c.41A>G), located in coding exon 1 of the GABRG2 gene, results from an A to G substitution at nucleotide position 41. The tyrosine at codon 14 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant was previously reported in the SNPDatabase as rs61750979, but was absent from population-based cohorts in the NHLBI Exome Sequencing Project (ESP) and 1000 Genomes Project databases. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000794979 | SCV000934417 | likely benign | Epilepsy, childhood absence 2; Febrile seizures, familial, 8 | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000998484 | SCV001154580 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | GABRG2: BP4, BS2 |
Illumina Laboratory Services, |
RCV001153518 | SCV001314813 | uncertain significance | Epilepsy, childhood absence 2 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |